Assistant Professor, Urology, University of Texas Southwestern Medical Center, Southwestern Medical School
Urology
Dr. Vitaly Margulis, MD
|
|
Give Review
Vitaly Margulis works in the field of Urology. He went to University of Texas Southwestern Medical School. He received 4 awards: "Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification", "Super Doctor" and "Fellow (FACS)". Vitaly Margulis is a published doctor. He published 95 publications, including: 'Urothelial cancer of the urinary bladder, can lessons learned be applied to the upper urinary tract?' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Prognostic Role of Cell Cycle and Proliferative Markers in Clear Cell Renal Cell Carcinoma.
- Do Referral Patterns in Adolescents and Young Adults with Testicular Cancer Impact Oncologic Outcomes?
- The Utility of Chest X-Rays for T1a Renal Cell Carcinoma Surveillance.
- Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies.
- Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments.
- Editorial Comment from Dr Haddad and Dr Margulis to Prognostic factors of recurrent disease in upper urinary tract urothelial Cancer after radical nephroureterectomy: ...
- Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: A multi-institutional study.
- Association of distance to treatment facility on quality and survival outcomes after radical cystectomy for Bladder cancer.
- Stereotactic Radiation Therapy of Renal Cancer Inferior Vena Cava Tumor Thrombus.
- Lynch Syndrome: A Primer for Urologists and Panel Recommendations.
- Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward.
- Feasibility of obtaining biomarker profiles from endoscopic biopsy specimens in upper tract urothelial carcinoma: Preliminary results.
- Evaluation of the prognostic significance of altered Mammalian target of rapamycin pathway biomarkers in upper tract urothelial carcinoma.
- Spectrum of diverse genomic alterations define non-clear cell Renal carcinoma subtypes.
- Multi-Institutional Validation of the Predictive Value of KI-67 in Patients with High-Grade Urothelial Carcinoma of the Upper Urinary Tract.
- Oncologic outcomes following surgical resection of Renal cell carcinoma with inferior vena caval thrombus extending above the hepatic veins: a contemporary multicenter...
- Validation of mammalian target of rapamycin biomarker panel in patients with clear cell Renal cell carcinoma.
- Editorial Comment to Equivalent survival and improved preservation of Renal function after distal ureterectomy compared with nephroureterectomy in patients with urothe...
- Degree of Hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract.
- Risk stratification of pubertal children and postpubertal adolescents with clinical stage I Testicular nonseminomatous germ cell tumors.
- Association of perioperative Blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
- Surgical management of metastatic Renal cell carcinoma in the era of targeted therapies.
- Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma.
- Diagnosis and management of upper tract urothelial carcinoma.
- Surgical Management of Renal Cell Carcinoma.
- Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
- Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: Results of a current series and a revie...
- Insulin-like Growth Factor Messenger RNA-binding Protein 3 Expression Helps Prognostication in Patients with Upper Tract Urothelial Carcinoma.
- Perioperative Outcomes Following Surgical Resection of Renal Cell Carcinoma with Inferior Vena Cava Thrombus Extending Above the Hepatic Veins: A Contemporary Multicen...
- Dysregulation of beta-catenin is an independent predictor of oncological outcomes in patients with clear cell Renal cell carcinoma.
- A comparison of pediatric, adolescent, and adult Testicular germ cell malignancy.
- The use of preoperative targeted molecular therapy to allow nephron sparing for T1b tumors.
- Prediction of Intravesical Recurrence After Radical Nephroureterectomy: Development of a Clinical Decision-making Tool.
- Prospective comparison of molecular signatures in urothelial cancer of the Bladder and the upper urinary tract: is there evidence for discordant biology?
- Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
- BAP1 immunohistochemistry in a multi-institutional cohort predicts outcomes in patients with clear cell Renal cell carcinoma.
- Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy.
- Ki-67 is an independent predictor of oncological outcomes in patients with high-grade upper tract urothelial carcinoma: results of a prospective analysis and a review ...
- Urothelial carcinoma at the uretero-enteric junction: multi-center evaluation of oncologic outcomes after radical nephroureterectomy.
- Impact of statin use on oncologic outcomes of patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
- Prognostic Role of Cell Cycle and Proliferative Biomarkers in Patients with Clear Cell Renal Cell Carcinoma.
- Ki67 is an independent predictor of oncological outcomes in patients with localized clear-cell Renal cell carcinoma.
- Prediction of Cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using ...
- Assessing treatment response after induction Bacillus Calmette-Guerin for carcinoma in situ of the urinary Bladder: can post-induction random Bladder biopsies be avoided?
- Rapid progression of a germ cell tumor encasing the inferior vena cava and aorta following a radical orchiectomy.
- Prospective Evaluation of a Molecular Marker Panel for Prediction of Recurrence and Cancer-specific Survival After Radical Cystectomy.
- Evaluation of anatomic and morphologic nomogram to predict malignant and high-grade disease in a cohort of patients with small Renal masses.
- Impact of Renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy.
- Comparative Analysis of Oncologic Outcomes of Partial Ureterectomy vs Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma.
- Gender-Specific effect of smoking on upper tract urothelial carcinoma outcomes.
- Preoperative pulmonary embolism does not predict poor postsurgical outcomes in RCC patients with venous thrombus.
- Lymphovascular invasion in clear cell renal cell carcinoma-Association with disease-free and Cancer-specific survival.
- Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy.
- Metabolism of kidney Cancer: from the lab to clinical practice.
- Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma.
- Cumulative Number of Altered Biomarkers in Mammalian Target of Rapamycin Pathway Is an Independent Predictor of Outcome in Patients With Clear Cell Renal Cell Carcinoma.
- The Role of Systemic Chemotherapy in Management of Upper Tract Urothelial Cancer.
- Risk of Cancer-specific mortality following recurrence after radical nephroureterectomy.
- Development of Accurate Models for Individualized Prediction of Survival After Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma.
- Effect of Testicular Germ Cell Tumor Therapy on Renal Function.
- Prospective evaluation of molecular markers for the staging and prognosis of upper tract urothelial carcinoma.
- Risk prediction in the management of small Renal masses.
- BAP1 loss defines a new class of Renal cell carcinoma.
- A validated tumorgraft model reveals activity of dovitinib against Renal cell carcinoma.
- The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma.
- Obesity adversely impacts disease Specific outcomes in patients with upper tract urothelial carcinoma.
- The impact of targeted molecular therapies on the level of Renal cell carcinoma vena caval tumor thrombus.
- Reply from Authors re: Axel Bex, Noel Clarke. Targeted Caval Cytoreduction: Solid Foundations or Shifting Sands? Eur Urol 2011;59:919-20.
- Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study.
- Prognostic effect of urinary Bladder carcinoma in situ on clinical outcome of subsequent upper tract urothelial carcinoma.
- Development and characterization of clinically relevant tumor models from patients with Renal cell carcinoma.
- Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration.
- Assessment of Hematuria.
- Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy.
- Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract.
- Upper tract urothelial carcinoma: Impact of time to surgery.
- Penile Cancer: management of regional lymphatic drainage.
- Fifth joint meeting of the American Urological Association and the Japanese Urological Association International Affiliate Society Meeting at the 105th Annual Meeting ...
- Can we better select patients with metastatic Renal cell carcinoma for cytoreductive nephrectomy?
- Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract.
- Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma.
- Advanced patient age is associated with inferior Cancer-specific survival after radical nephroureterectomy.
- In search of a better crystal ball: recent advances in prognostic markers for clear-cell Renal cell carcinoma.
- Concomitant carcinoma in situ is a feature of aggressive Disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy.
- Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?
- Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases.
- Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial Cancer.
- The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should ...
- Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration.
- Role of cytoreductive nephrectomy in Renal cell carcinoma.
- Clinical trials: nationally representative data in urology.
- Impact of lymph node dissection on Cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
- Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian Cancer screening trial and national lung screening trial.
- Urothelial cancer of the urinary Bladder, can lessons learned be applied to the upper urinary tract?
Schools
University of Texas Southwestern Medical Center At Dallas
University Tx Southwestern Med School
Procedures Preformed
- AdRenalectomy
- Complete Nephrectomy With Robotic Assistance
- Cystectomy
- Cystotomy
- View All
Conditions Treated
- Balanoposthitis
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
- Fellow (FACS)
Education
-
University of Texas MD Anderson Cancer Center -
University of Texas Southwestern Medical School
Hospital
-
Children's Health System of Texas -
Veterans Affairs North Texas Health Care System -
University of Texas Southwestern Medical Center
Drug Facts
| NPI NUMBER | 1134152937 | |
| NPPES Provider LastName | MARGULIS | |
| NPPES Provider FirstName | VITALY | |
| NPPES Provider ZIPCode | 753909110 | |
| NPPES Provider State | TX | |
| Specialty Description | Urology | |
| Total Claim Count | 292.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 34.0 | |
| Percent Opioid Claims | 11.64 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1134152937 |
| Last Name Of The Provider | MARGULIS |
| First Name Of The Provider | VITALY |
| View All |
Similar Doctors
|
|
Dr. Claus G. Roehrborn, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey A. Cadeddu, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Matthew D. Shuford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary E. Lemack, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey C. Toubin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John R. Ware, MD |
|
|
Dr. Eric B. Smith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph L. Lamanna III, DO |
|
|
Dr. Linda A. Baker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James S. Cochran, MD |
|
|
Dr. Ginger B. Isom-Batz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mitchell O. Moskowitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony J. Perri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jodi Antonelli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew L. Wilner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Casey A. Seideman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arthur W. Shannon Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey M. Shoss, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Jacqueline D. Smith, MS
This Doctor is OpenDoctor Recommended.
|